"EOSINOPHILIA PREVALENCE IN HOSPITALIZED PATIENTS WITH ASTHMA EXACERBATION: A CROSS-SECTIONAL STUDY"
Main Article Content
Keywords
Asthma, Eosinophil’s, Exacerbation, Pathogenesis, Prevelance
Abstract
Eosinophilia is a common feature of asthma exacerbation and has been associated with increased disease severity and poorer treatment outcomes. However, limited data are available on the prevalence of eosinophilia in hospitalized patients with asthma exacerbation in Karachi, Pakistan. This study aimed to determine the prevalence of eosinophilia in this population. A cross-sectional study was conducted in multiple hospitals in Karachi, Pakistan. Patients admitted with a diagnosis of asthma exacerbation were included in the study. Blood samples were collected from each participant, and complete blood count analysis was performed to determine the absolute eosinophil count. Demographic and clinical data were also collected. A total of 70 patients were included in the study. The prevalence of eosinophilia in hospitalized patients with asthma exacerbation was found to be 39. Subgroup analyses based on age, gender, and asthma severity revealed variations in the prevalence of eosinophilia. Additionally, factors such as smoking, air pollution, and obesity were identified as potential contributors to severe asthma exacerbation. This study provides valuable insights into the prevalence of eosinophilia in hospitalized patients with asthma exacerbation in Karachi, Pakistan. The findings highlight the need for targeted interventions to address eosinophilia and its associated factors in order to improve asthma management and treatment outcomes. Further research is warranted to explore the underlying mechanisms and develop personalized approaches for the management of eosinophilic asthma exacerbation in this population.
References
2. Briggs, A., Nasser, S., Hammerby, E., Buchs, S., & Virchow, J. C. (2021). The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data. Journal of patient-reported outcomes, 5, 1-9.
3. Gautam, Y., Johansson, E., & Mersha, T. B. (2022). Multi-omics profiling approach to asthma: an evolving paradigm. Journal of Personalized Medicine, 12(1), 66.
4. Li, B., Wang, Y., Wang, Z., Li, X., Kay, S., Chupp, G. L., ... & Gomez, J. L. (2023). Shared Genetic Architecture of Blood Eosinophil Counts and Asthma in UK Biobank. ERJ Open Research.
5. Busse, W. W., Kraft, M., Rabe, K. F., Deniz, Y., Rowe, P. J., Ruddy, M., & Castro, M. (2021). Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation. European Respiratory Journal, 58(2).
6. McDonald, V. M., Osadnik, C. R., & Gibson, P. G. (2019). Treatable traits in acute exacerbations of chronic airway diseases. Chronic respiratory disease, 16, 1479973119867954.
7. Liu, S., Cao, Y., Du, T., & Zhi, Y. (2021). Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and meta-analysis. The Journal of Allergy and Clinical Immunology: In Practice, 9(2), 693-701.
8. Bachani, P., Kumar, L., Kumar, N., Memon, M. K., Memon, S., Irfan, S& Kumar, B. (2020). Prevalence and Symptom Characteristics of Irritable Bowel Syndrome Among Bronchial Asthma Patients in Pakistan. Cureus, 12(12).
9. Yasin, M., Adeel, M., Muhammad, M., Sadaf, S., Tareen, S., & Jan, F. (2021). Frequency of Eosinophilia in Patients with Bronchial Asthma in Khyber Pakhtunkhwa. Pakistan Journal of Chest Medicine, 27(3), 117-120.
10. Solomon, Y., Woldu, B., Mesfin, N., & Enawgaw, B. (2022). Selected hematological abnormalities and their associated factors among asthmatic patients in Northwest Ethiopia: a cross-sectional study. BMC Pulmonary Medicine, 22(1), 1-14.
11. Ahmad, W., Ashraf, S., Wahab, A., Farooqi, R., & Ahmad, H. (2020). Frequency of Blood Eosinophilia in COPD Patients admitted with Acute Exacerbation. Pakistan Journal of Chest Medicine, 26(1), 28-32.
12. Wang, J., Zhou, Y., Zhang, H., Hu, L., Liu, J., Wang, L., ... & Wang, Q. (2023). Pathogenesis of allergic diseases and implications for therapeutic interventions. Signal Transduction and Targeted Therapy, 8(1), 138.
13. Hartley, K., Ryan, P. H., Gillespie, G. L., Perazzo, J., Wright, J. M., Rice, G. E., ... & Brokamp, C. (2022). Residential greenness, asthma, and lung function among children at high risk of allergic sensitization: a prospective cohort study. Environmental Health, 21(1), 1-11.
14. Sözener, Z. C., Cevhertas, L., Nadeau, K., Akdis, M., & Akdis, C. A. (2020). Environmental factors in epithelial barrier dysfunction. Journal of Allergy and Clinical Immunology, 145(6), 1517-1528.
15. Soma, T., & Nagata, M. (2022). Immunosenescence, inflammaging, and lung senescence in asthma in the elderly. Biomolecules, 12(10), 1456.
16. Lee, Y. G., Lee, P. H., Choi, S. M., An, M. H., & Jang, A. S. (2021). Effects of air pollutants on airway diseases. International journal of environmental research and public health, 18(18), 9905.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Mahrukh khursheed
Department of Pharmacology, Jinnah University for Women, Karachi, Pakistan
Zehra Ashraf
Department of Pharmacy Practice, Jinnah University for Women, Karachi, Pakistan.
Qurat ul Ain Waseem
Department of Pharmacy Practice, Jinnah University for Women, Karachi, Pakistan.
Mehwish khan
Department of Pharmacognosy, Jinnah University for Women, Karachi, Pakistan.
Wasim Sarwar Bhatti
Gambat Institute of Medical Sciences
Nadeem Baloch
Institute of Pharmacy, Shaheed Mohtarma Benazir Bhutto Medical University
Waseem Abbas
Institute of Pharmacy, Shaheed Mohtarma Benazir Bhutto Medical University